Provided are a series of BTK inhibitors, and specifically disclosed are a compound, pharmaceutically acceptable salt thereof, tautomer thereof or prodrug thereof represented by formula (I), (II), (III) or (IV). ##STR00001##

Provided are a series of BTK inhibitors, and specifically disclosed are a compound, pharmaceutically acceptable salt thereof, tautomer thereof or prodrug thereof represented by formula (I), (II), (III) or (IV). ##STR00001##

A fiber-treating agent including a condensate formed from the following components (A) and (B), and a component (C). A total content of a constituent element derived from the component (A) and a constituent element derived from the component (B) is more than 1 mass %, and a turbidity is 1,000 NTU or less: (A): formaldehyde or a hydrate thereof, (B): triazine or a derivative thereof of formula (1):

##STR00001## where R.sup.1 to R.sup.3 are the same or different, and each represent a hydrogen atom, a hydroxymethylamino group, an amino group, a hydroxy group, a halogen atom, a phenyl group, a linear or branched alkyl group or alkenyl group having 1 or more and 6 or less carbon atoms, or a linear or branched alkoxy group or alkenyloxy group having 1 or more and 6 or less carbon atoms, and (C): water.

A fiber-treating agent including a condensate formed from the following components (A) and (B), and a component (C). A total content of a constituent element derived from the component (A) and a constituent element derived from the component (B) is more than 1 mass %, and a turbidity is 1,000 NTU or less: (A): formaldehyde or a hydrate thereof, (B): triazine or a derivative thereof of formula (1):

##STR00001## where R.sup.1 to R.sup.3 are the same or different, and each represent a hydrogen atom, a hydroxymethylamino group, an amino group, a hydroxy group, a halogen atom, a phenyl group, a linear or branched alkyl group or alkenyl group having 1 or more and 6 or less carbon atoms, or a linear or branched alkoxy group or alkenyloxy group having 1 or more and 6 or less carbon atoms, and (C): water.

Disclosed are adsorption complexes that include 1-methylcyclopropene (1-MCP) and a metal coordination polymer network (MCPN), wherein the MCPN is a porous material, and the 1-MCP is adsorbed into the MCPN. Also disclosed are kits for containing 1-MCP that include the adsorption complex in a 1-MCP-impermeable package. Also disclosed are methods of releasing 1-methylcyclopropene (1-MCP) from the kit that include the application of aqueous fluids, heat, and/or pressure.

Disclosed are adsorption complexes that include 1-methylcyclopropene (1-MCP) and a metal coordination polymer network (MCPN), wherein the MCPN is a porous material, and the 1-MCP is adsorbed into the MCPN. Also disclosed are kits for containing 1-MCP that include the adsorption complex in a 1-MCP-impermeable package. Also disclosed are methods of releasing 1-methylcyclopropene (1-MCP) from the kit that include the application of aqueous fluids, heat, and/or pressure.

The present specification relates to a double spiro structure compound, and an organic light emitting device comprising the same.

The present specification relates to a double spiro structure compound, and an organic light emitting device comprising the same.

The present specification relates to a cyclic compound and an organic light emitting device comprising the same.

The present specification relates to a cyclic compound and an organic light emitting device comprising the same.